2 completed, 1 recruiting. 3 Phase 1.
By phase and status
Follow KarX-EC: new trials by email Literature Review of KarX-EC trials Research Report on KarX-EC
Trials (filtered) newest first · largest first
All 3 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses Xanomeline/Trospium Chloride Capsule, Xanomeline Enteric Capsule, Trospium Chloride - Healthy Volunteers | Phase 1 | Recruiting | 236 | 2025-06-27 | 2026-08-17 |
Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-release Trospium Chloride in Adolescents With Psychiatric Disorders KarXT, KarX-EC - Psychiatric Disorders | Phase 1 | Completed | 24 | 2025-04-29 | 2025-08-06 |
A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Xanomeline With Trospium Chloride Versus KarXT in Healthy Adult and Elderly Participants of Japanese Ethnicity and to Assess the Effect of Omeprazole on the PK of Xanomeline With Trospium Chloride in Healthy Adult Participants KarXT, KarX-EC, Placebo - Healthy Volunteers | Phase 1 | Completed | 78 | 2024-10-01 | 2025-07-04 |
Conditions studied
Mental Disorders (1)
Sponsors
Bristol-Myers Squibb (2) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company (1)
Countries
United States (2) · United Kingdom (1)